Company intelligence / Profile preview

Jiangsu Chenpai Pharmaceutical Group

Ownership: Private
Development stage: Commercial

Overview

Jiangsu Chenpai Pharmaceutical Group is a pharmaceutical manufacturer based in Haimen, Jiangsu Province, China. The company develops and manufactures pharmaceutical products including small molecule drugs such as voglibose dispersible tablets. It has completed clinical trials and submitted an NDA for this product, indicating commercial-stage activity. The company is active and operates primarily within the Chinese market.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

piracetam

Commercial

Indications: Cerebrovascular disease, Traumatic brain injury, Toxic encephalopathy

Beyond the preview

Go deeper on Jiangsu Chenpai Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Chenpai Pharmaceutical Group.

Explore the full profile